UK drug firm AstraZeneca has rejected a 'final' takeover bid from US rival Pfizer.
Pfizer had upped its offer for AstraZeneca to $116bn – in cash and shares.
Pfizer, the world's largest drug company, says this latest bid is its final attempt to persuade AstraZeneca to negotiate a merger.
Speaking to our London Correspondent Olly Barratt FSN's Kevin McAleese began by asking him why this latest bid was rejected?
IN: well Astrazeneca
OUT: are dead
DUR: 2:32
http://www.fsnradionews.com/feeds/0519astra-ob-generic.mp3
The latest radio news & feature packages from FSN Bureaus worldwide.